🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ziftomenib is an investigational drug in development for the treatment of p...
Status
Recruiting
Location
Mayo Clinic - Phoenix
Start Date
2023-07-18
Trial ID
NCT05735184
Treatments Being Tested
The goal of Part 1 of this clinical research study is to learn about the sa...
Status
Terminated
Location
University of Texas MD Anderson Cancer Center
Start Date
2010-08
Trial ID
NCT01160354
Treatments Being Tested
A study consisting of a dose-escalation phase and a dose-expansion phase to...
Status
Terminated
Location
Emory University
Start Date
2020-09-22
Trial ID
NCT04422210
Treatments Being Tested
This is a non-randomized, open-label, Phase Ib study of atezolizumab in com...
Status
Completed
Location
City of Hope
Start Date
2016-10-31
Trial ID
NCT02892318
Treatments Being Tested
The aims of the study are: * to assess the safety profile of danavorexton ...
Status
Completed
Location
Endeavor Clinical Trials
Start Date
2021-09-28
Trial ID
NCT05025397
Treatments Being Tested
The purpose of this study is to determine the recommended Phase 2 dose (RP2...
Status
Active Not Recruiting
Location
The University of Alabama at Birmingham
Start Date
2022-10-04
Trial ID
NCT05453903
Treatments Being Tested
Xfibra, Inc. is conducting a Phase 1, randomized, double-blind, placebo-con...
Status
Recruiting
Location
AMR Clinical
Start Date
2026-02-17
Trial ID
NCT05361733
THINK (THerapeutic Immunotherapy with NKR-2) is a multinational (EU/US) ope...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT03018405
Treatments Being Tested
This is a trial to compare neurocognitive outcomes in the intent-to-treat p...
Status
Not Yet Recruiting
Location
Children's of Alabama
Start Date
2026-07-01
Trial ID
NCT07291102